125561 Now

Under number 125561 , written evidence was submitted by Mrs. C. Roche to the UK Parliament regarding the impact of screen time and "digital drugs" on children’s brains and ADHD .

The application was submitted by Alexion Pharmaceuticals and received FDA approval in September 2015 . Academic & Technical Research 125561

It is an enzyme replacement therapy used to treat Lysosomal Acid Lipase (LAL) deficiency , a rare genetic condition. Under number 125561 , written evidence was submitted by Mrs

The number also serves as a specific article identifier (often part of a DOI or page reference) in various scientific journals: Under number 125561